AnserBio
PrivateLast Round
Seed
Dec 1, 2021
Total Funding Raised
$6.45M
Company Overview
AnserBio is a biotechnology company developing a novel class of therapeutics for oncology treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnserBio Comparables
Compare AnserBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| p53-Therapeutics, Inc. | 78% | |
| Evox Therapeutics | 68% | |
| PMV Pharma | 66% |
AnserBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2021 |
AnserBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Seed |
| Peregrine Ventures | Seed |
| ExitValley | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 116% MoM, reaching 1.3K.
- Dec 1, 2021
$6.45M round led by Israel Biotech Fund and Peregrine Ventures
AnserBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AnserBio's valuation, stock price, and market status.
Is AnserBio a public or private company?
AnserBio is a private company.
What is the current stock price of AnserBio?
AnserBio is a private company with no public stock price. No recent secondary market data is available.
How much is AnserBio worth (valuation)?
Valuation information for AnserBio is not publicly available.
Can I buy AnserBio stock?
AnserBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AnserBio's last funding round?
AnserBio's most recent funding round was Seed on December 1, 2021.
Who are the main investors in AnserBio?
Key investors in AnserBio include Israel Biotech Fund, Peregrine Ventures, ExitValley.
Will AnserBio IPO soon?
No public IPO plans have been announced for AnserBio.
How can I track AnserBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AnserBio's secondary market activity and sign up for updates.